Kathleen M. Egan

11.0k total citations · 1 hit paper
159 papers, 7.8k citations indexed

About

Kathleen M. Egan is a scholar working on Oncology, Ophthalmology and Molecular Biology. According to data from OpenAlex, Kathleen M. Egan has authored 159 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 37 papers in Ophthalmology and 35 papers in Molecular Biology. Recurrent topics in Kathleen M. Egan's work include Ocular Oncology and Treatments (35 papers), Cancer Risks and Factors (30 papers) and Glioma Diagnosis and Treatment (13 papers). Kathleen M. Egan is often cited by papers focused on Ocular Oncology and Treatments (35 papers), Cancer Risks and Factors (30 papers) and Glioma Diagnosis and Treatment (13 papers). Kathleen M. Egan collaborates with scholars based in United States, Netherlands and United Kingdom. Kathleen M. Egan's co-authors include Walter C. Willett, Meir J. Stampfer, Evangelos S. Gragoudas, Polly A. Newcomb, Amy Trentham‐Dietz, Linda Titus‐Ernstoff, Graham A. Colditz, Johanna M. Seddon, John E. Munzenrider and David J. Hunter and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Kathleen M. Egan

157 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aspirin and the Risk of Colorectal Cancer in Women

1995 906 citations Kathleen M. Egan, David J. Hunter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen M. Egan United States	49	2.8k	1.9k	1.6k	1.1k	1.1k	159	7.8k
Alessandro Antonelli Italy	63	2.3k 0.8×	332 0.2×	2.3k 1.5×	673 0.6×	1.7k 1.6×	351	13.4k
Takamasa Kayama Japan	49	829 0.3×	582 0.3×	2.3k 1.4×	698 0.6×	294 0.3×	344	7.7k
Zoltán Szekanecz Hungary	63	1.5k 0.5×	204 0.1×	2.3k 1.4×	534 0.5×	581 0.5×	326	12.1k
Tatsuya Kondo Japan	43	703 0.3×	264 0.1×	3.6k 2.3×	643 0.6×	547 0.5×	183	8.3k
Oliver FitzGerald Ireland	66	1.1k 0.4×	160 0.1×	2.2k 1.3×	536 0.5×	469 0.4×	471	14.6k
Loretta M. Itri United States	38	4.0k 1.4×	132 0.1×	3.5k 2.2×	646 0.6×	879 0.8×	91	10.9k
Poupak Fallahi Italy	59	2.1k 0.8×	163 0.1×	1.9k 1.2×	530 0.5×	1.6k 1.5×	298	10.8k
Naoyuki Kamatani Japan	58	2.1k 0.8×	123 0.1×	5.3k 3.3×	911 0.8×	1.4k 1.3×	344	13.5k
Fang Zheng China	37	516 0.2×	2.5k 1.3×	1.9k 1.2×	824 0.7×	217 0.2×	248	6.7k
Marta Di Nicola Italy	40	443 0.2×	1.6k 0.9×	1.2k 0.8×	451 0.4×	160 0.1×	270	6.3k

Countries citing papers authored by Kathleen M. Egan

Since Specialization

Citations

This map shows the geographic impact of Kathleen M. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen M. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen M. Egan more than expected).

Fields of papers citing papers by Kathleen M. Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen M. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen M. Egan. The network helps show where Kathleen M. Egan may publish in the future.

Co-authorship network of co-authors of Kathleen M. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen M. Egan. A scholar is included among the top collaborators of Kathleen M. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen M. Egan. Kathleen M. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peeri, Noah C., Jamie K. Teer, Burt Nabors, et al.. (2025). Glioma grade and mortality in relation to sequence variation in the mitochondrial genome. Cancer Genetics. 294-295. 171–180. 1 indexed citations

Turner, Kea, Oliver T. Nguyen, Jessica Y. Islam, et al.. (2024). Patient-provider communication about the use of medical cannabis for cancer symptoms: a cross-sectional study. JNCI Monographs. 2024(66). 298–304. 1 indexed citations

Yaghjyan, Lusine, Volker Mai, Lancia Darville, et al.. (2023). Associations of gut microbiome with endogenous estrogen levels in healthy postmenopausal women. Cancer Causes & Control. 34(10). 873–881. 1 indexed citations

Mokhtari, Sepideh, Noah C. Peeri, André Beer‐Furlan, et al.. (2023). Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series. British Journal of Neurosurgery. 39(2). 224–227. 1 indexed citations

Chen, Dongquan, Casey D. Morrow, Burt Nabors, et al.. (2023). MODL-06. THE GUT MICROBIOTA OF BRAIN TUMOR PATIENTS CAN IMPACT IMMUNOTHERAPY EFFICACY IN A PRECLINICAL MODEL OF GLIOMA. Neuro-Oncology. 25(Supplement_5). v299–v299. 3 indexed citations

Ogony, Joshua, Derek C. Radisky, Kathryn J. Ruddy, et al.. (2020). Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women. Cancer Prevention Research. 13(11). 901–910. 10 indexed citations

Reblin, Maija, Solmaz Sahebjam, Noah C. Peeri, et al.. (2019). Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida. Journal of Palliative Medicine. 22(10). 1202–1207. 26 indexed citations

Striley, Catherine W., et al.. (2018). Interactions between Alcohol Consumption and Adjuvant Hormone Therapy in Relation to Breast Cancer-Free Survival. Journal of Breast Cancer. 21(2). 158–158. 4 indexed citations

Newcomb, Polly A., Ellen Kampman, Amy Trentham‐Dietz, et al.. (2013). Alcohol Consumption Before and After Breast Cancer Diagnosis: Associations With Survival From Breast Cancer, Cardiovascular Disease, and Other Causes. Journal of Clinical Oncology. 31(16). 1939–1946. 48 indexed citations

10.

Anic, Gabriella M., Reid C. Thompson, Burt Nabors, et al.. (2012). An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome. Cancer Causes & Control. 23(9). 1443–1449. 32 indexed citations

11.

Heine, John, Walker H. Land, & Kathleen M. Egan. (2011). Statistical learning techniques applied to epidemiology: a simulated case-control comparison study with logistic regression. BMC Bioinformatics. 12(1). 37–37. 5 indexed citations

12.

Egan, Kathleen M.. (2010). Cross Lingual Arabic Blog Alerting (COLABA). Conference of the Association for Machine Translation in the Americas. 2 indexed citations

13.

Anic, Gabriella M., Linda Titus‐Ernstoff, Polly A. Newcomb, Amy Trentham‐Dietz, & Kathleen M. Egan. (2010). Sleep duration and obesity in a population-based study. Sleep Medicine. 11(5). 447–451. 52 indexed citations

14.

Egan, Kathleen M., Lisa B. Signorello, Heather M. Munro, et al.. (2007). Vitamin D insufficiency among African Americans in the southeastern United States: Implications for cancer disparities.. Cancer Epidemiology and Prevention Biomarkers. 16. 29 indexed citations

15.

Egan, Kathleen M., Polly A. Newcomb, Linda Titus‐Ernstoff, et al.. (2003). Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case–control study (United States). Cancer Causes & Control. 14(1). 43–51. 21 indexed citations

16.

Egan, Kathleen M., et al.. (2002). Newsroom OnTAP: real-time alerting from streaming audio. 391–392. 1 indexed citations

17.

Baron, John A., Elisabete Weiderpass, Polly A. Newcomb, et al.. (2001). Metabolic disorders and breast cancer risk (United States). Cancer Causes & Control. 12(10). 875–880. 73 indexed citations

18.

Egan, Kathleen M., Meir J. Stampfer, Bernard Rosner, et al.. (1998). Risk factors for breast cancer in women with a breast cancer family history.. PubMed. 7(5). 359–64. 61 indexed citations

19.

Friedman, Ephraim, Sara Krupsky, Anne Marie Lane, et al.. (1995). Ocular Blood Flow Velocity in Age-related Macular Degeneration. Ophthalmology. 102(4). 640–646. 201 indexed citations

20.

Gragoudas, Evangelos S., Kathleen M. Egan, Johanna M. Seddon, et al.. (1991). Survival of Patents with Metastases from Uveal Melanoma. Ophthalmology. 98(3). 383–390. 279 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact